Table 4.

Variables that affect outcomes of unrelated donor transplants in chronic myelogenous leukemia (CML).

Outcome
Variable (Reference)
GVHD
Survival
Chronic phase status at time of SCT (59,62)  -   +  
Serologic mismatch Class I or II (59,61,65)  +   0  
Molecular mismatch (62,66,67)  +   -  
Older age (59,62)  0   -  
Transplant < 12 months from diagnosis (59,62)  0   +  
CMV positivity (59,61)  0   -  
T-cell depletion (59)  -   0  
Abbreviations: GVHD, graft-versus-host disease; -, negative effect; +, positive effect; 0, no significant effect  
Outcome
Variable (Reference)
GVHD
Survival
Chronic phase status at time of SCT (59,62)  -   +  
Serologic mismatch Class I or II (59,61,65)  +   0  
Molecular mismatch (62,66,67)  +   -  
Older age (59,62)  0   -  
Transplant < 12 months from diagnosis (59,62)  0   +  
CMV positivity (59,61)  0   -  
T-cell depletion (59)  -   0  
Abbreviations: GVHD, graft-versus-host disease; -, negative effect; +, positive effect; 0, no significant effect  
Close Modal

or Create an Account

Close Modal
Close Modal